BioSight
Companies
ADMA BIOLOGICS, INC. logo

ADMA

NASDAQRAMSEY, NJ
ADMA BIOLOGICS, INC.

ADMA Biologics manufactures and commercializes plasma-derived immunoglobulin products, including ASCENIV and BIVIGAM, which are used for immune deficiency treatment. The firm relies on sourcing FDA-approved human plasma and contracts with third-party vendors for manufacturing and testing. ADMA is in the commercial stage with approved products on the market, though it continues to navigate manufacturing and supply chain challenges.

Price history not yet available for ADMA.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar